Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Extension Study of the Safety and Efficacy of CLS-TA for Treatment of Macular Edema Associated with Non-infectious Uveitis (MAGNOLIA)” in the latest issue of the British Journal of Ophthalmology.
Macula Edema and Non-infectious Uveitis
With uveitis, the body’s immune system attacks the eye, causing inflammation. Noninfectious uveitis can result from an eye injury or a disease somewhere else in the body. Macula edema can be a complication of non-infectious uveitis. It is a build up of fluid in the macula, the part of the retina responsible for central vision.
CLS-TA Treatment
This study assessed the extended safety and efficacy of suprachoridal triamcinolone acetonide injectable suspension (CLS-TA) among patients with macular edema secondary to non-infectious uveitis. It concluded that approximately 50% of patients did not require additional treatment for up to 9 months following the last CLS-TA injection. In addition, no serious adverse events were observed.
You can access the full abstract here.
About Dr. Wang
One of Texas Retina Associates’ 17 retina specialists, Dr. Wang sub-specializes in the diagnosis and treatment of uveitis. He sees patients in our Dallas Main, Dallas North, Plano and Sherman offices. Dr. Wang also serves as Director of Clinical Research for our Plano office. You can learn more about him here.